PATENT CLAIM ANALYSIS

Application Number: 15767086
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
This invention presents the method and use of the AAV-XBP1s/GFP virus, in the prevention and treatment of amyotrophic lateral sclerosis, as presented in the in vivo studies in FIG.  6.

Claim (Index 67):
The method of  claim 54 , wherein the vector is administered to the mammal in a pharmaceutical composition further comprising a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.41667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15327011', '12328267', '12417910', '15126688', '14445670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.655152096616268
- 35 USC 102 Novelty (BERT): 0.523232607069016
- Combined Prediction Score: 0.6419601476615429
- Mean Citation Score: 263.60930399999995
- Max Citation Score: 288.1689
- Similarity Product: 181.85331005541087

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test